logo
Cerebrospinal Fluid Viral Load in HIV-1-Infected Patients Without Antiretroviral Treatment
Marked Inhibitory Activity of Masked Aryloxy Aminoacyl Phosphoramidate Derivatives of Dideoxynucleoside Analogues Against Visna Virus Infection
Unintegrated Circular HIV-1 DNA in the Peripheral Mononuclear Cells of HIV-1-Infected Subjects: Association With High Levels of Plasma HIV-1 RNA, Rapid Decline in CD4 Count, and Clinical Progression to AIDS
Virologic, Immunologic, and Clinical Parameters in the Incidence and Progression of Anal Squamous Intraepithelial Lesions in HIV-Positive and HIV-Negative Homosexual Men
Anal Squamous Intraepithelial Lesions in HIV-Positive and HIV-Negative Homosexual and Bisexual Men
Safety Study of Nonoxynol-9 as a Vaginal Microbicide: Evidence of Adverse Effects
Laboratory Test Differences Associated With HTLV-I and HTLV-II Infection
Randomized, Controlled Study of the Safety and Efficacy of Intravenous Cidofovir for the Treatment of Relapsing Cytomegalovirus Retinitis in Patients With AIDS
Size and Duration of Zidovudine Benefit in 1003 HIV-Infected Patients: U.S. Army, Navy, and Air Force Natural History Data
Evaluating the Cost of Medications for Ambulatory HIV-Infected Persons in Association With Landmark Changes in Antiretroviral Therapy
Unsafe Sex in Men Who Have Sex With Both Men and Women
The Social Context of Drinking, Drug Use, and Unsafe Sex in the Boston Young Men Study
Interpretation of Indeterminate HIV Serology Results in an Incarcerated Population
Prevalence of HTLV-I in Leprosy Patients in Two Sanatoriums in Japan
Announcement
The Second National AIDS Malignancy Conference
ASSOCIATION BETWEEN HHV8, HIV, CANCER AND SELECTED RISK FACTORS IN SOUTH AFRICA
HIV AND CANCER IN KAMPALA, UGANDA.
SEROLOGIC EVIDENCE FOR DIFFERENT ROUTES OF TRANSMISSION OF HHV-8 IN DIFFERENT POPULATIONS
INCREASED INCIDENCE OF INVASIVE CERVICAL CANCER (ICC) IN HIV+ WOMEN IN NEW YORK CITY.
MOLECULAR EPIDEMIOLOGY OF HPV INFECTIONS OF THE FEMALE GENITAL TRACT, IDENTIFIED BY A NOVEL PCR/RESTRICTION/SEQUENCING ANALYSIS OF RENAL TRANSPLANT CANDIDATES & RECIPIENTS AND OF HIV-POSITIVE PATIENTS.
HIV-1 TAT PROTEIN INCREASES INVASION OF HUMAN PAPILLOMAVIRUS TYPE 16 POSITIVE KERATINOCYTES
NON-AIDS DEFINING MALIGNANCIES IN THE MULTICENTER AIDS COHORT STUDY (MACS), 1984-1996
AZT, A GENOTOXIC TRANSPLACENTAL CARCINOGEN IN RODENTS, IS INCORPORATED INTO HUMAN FETAL AND MATERNAL DNA.
EPIDEMIOLOGIC STUDIES OF HUMAN HERPES VIRUS-8 IN ZIMBABWE.
FACTORS ASSOCIATED WITH AIDS-DEFINING LYMPHOMA AND KAPOSI'S SARCOMA (KS) IN MASSACHUSETTS (MA) ADULT/ADOLESCENT AIDS CASES.
HIV-RELATED MALIGNANCIES: A COMMUNITY BASED STUDY USING A LINKAGE OF CANCER REGISTRY AND HIV REGISTRY DATA
NON AIDS DEFINING MALIGNANCIES AMONG 5, 574 HIV SEROPOSITIVE MEMBERS OF A LARGE MANAGED CARE-BASED COHORT.
COLLECTION AND VERIFICATION OF MATCHED DATA FROM SELECTED UNITED STATES CANCER AND HIV/AIDS REGISTRIES
CANCER INCIDENCE AMONG HIV-NEGATIVE AND HIV-POSITIVE FORMER INTRAVENOUS DRUG USERS IN ITALY.
RISK OF CANCER OTHER THAN KS AND NHL IN PERSONS WITH AIDS IN ITALY.
WEALTH AND SOIL EXPOSURE ARE RISK FACTORS FOR ENDEMIC KAPOSI'S SARCOMA (KS) IN UGANDA.
Preliminary results of a phase II study of oral thalidomide in patients with AIDS-related Kaposl's sarcoma (KS)
AIDS-associated Kaposi's sarcoma and HIV-protease inhibitors
PHASE II STUDY OF LIPOSOMAL DOXORUBICIN (TLC D-99) IN THE TREATMENT OF AIDS-RELATED KAPOSI'S SARCOMA (KS).
PEGYLATED LIPOSOMAL DOXORUBICIN IN AIDS-RELATED KAPOSI'S SARCOMA
Cost effectiveness of liposomal Daunorubicin versus liposomal doxorubicin in Kaposi Sarcoma.
Recruitment in a Two-Stage Phase II Trial of AIDS Kaposi's Sarcoma Patients
INDUCTION OF APOPTOSIS SUBVERTS THE ABILITY OF BCBL-1 CELLS TO PRODUCE LARGE NUMBERS OF HHV8 VIRIONS IN RESPONSE TO BUTYRATE.
αIFN AND HIV-1 PROTEASE INHIBITORS (PI) INHIBIT HHV-8 INFECTION: POSSIBLE THERAPEUTIC APPROACHES FOR KAPOSI'S SARCOMA (KS)
Relationship of KSHV/HHV-8 Replication to Extent and Course of Kaposi's Sarcoma and Response to Therapy.
INTERLEUKIN 6 AND ONCOSTATIN M INDUCTION ARE ASSOCIATED WITH INCREASED RADIOSENSITIVITY IN KAPOSI'S SARCOMA CELLS
CONTORTROSTATIN INHIBITS KAPOSI'S SARCOMA INVASION AND ANGIOGENESIS.
AIDS-KAPOSI'S SARCOMA CELLS DEMONSTRATE INCREASED SUSCEPTIBILITY TO A REDOX CYCLING DRUG.
POSTTRANSPLANTATION PLASMACYTIC PROLIFERATION RELATED TO KAPOSI'S SARCOMA-ASSOCIATED HERPESVIRUS
KAPOSI'S SARCOMA-ASSOCIATED HERPESVIRUS (KSHV) INFECTION IN PROGRESSIVE HIV-RELATED LYMPHADENOPATHY (HIV-LAP).
ABSENCE OF HUMAN HERPESVIRUS 8 (HHV8) DNA IN URINE.
Semiquantitative Analysis of Human Herpesvirus-8 DNA in Kaposi's Sarcoma Specimens from HIV Infected Patients.
DETECTION OF ANTIBODIES IN HUMAN SERA AGAINST HHV-8/KSHV INDIVIDUAL RECOMBINANT PROTEINS.
PRESENCE OF HHV8 SEQUENCE IN THE ANALYSIS OF PEDIATRIC MALIGNANCIES.
INCREASED HUMAN HERPESVIRUS-8 COPY NUMBER AND VIRAL GENE EXPRESSION IN AIDS-KAPOSI'S SARCOMA PATIENTS PERIPHERAL BLOOD MONONUCLEAR CELLS CULTURED IN PRESENCE OF INFLAMMATORY CYTOKINES.
CLONING AND EXPRESSION OF HHV-8 GLYCOPROTEINS gH AND gL IN THE BACULOVIRUS SYSTEM.
EXPRESSION OF HUMAN HERPESVIRUS 8 (HHV-8) CELLULAR HOMOLOGUE GENES IN CLASSIC AND AIDS RELATED KAPOSI'S SARCOMAS.
EXPRESSION OF LATENT HHV-8 GENES
IDENTIFICATION OF CELLULAR AND VIRAL GENES POTENTIALLY INVOLVED IN HUMAN HERPESVIRUS (HHV)-8 PATHOGENESIS.
CHARACTERIZATION OF KSHV/HHV-8 G PROTEIN-COUPLED RECEPTOR (GPCR) TRANSCRIPTS: STRUCTURAL AND FUNCTIONAL CONSERVATION AMONG KAPOSI'S SARCOMA AND PRIMARY EFFUSION LYMPHOMA.
PEPTIDE MAPPING AND EXPRESSION OF KSHV ORF73
Transcriptional Analysis of Cantured Cellular Genes in the Cytokine Gene Locus of KSHV
TRANSCRIPTION MAPPING OF KSHV IN A BODY CAVITY-BASED LYMPHOMA CELL LINE (BC-1)
KAPOSI'S SARCOMA: A MULTICELLULAR, MULTIVIRAL PROCESS INITIATED BY RETROVIRAL INSERTIONAL MUTAGENESIS?
INHIBITION OF THE TRANSCRIPTION OF VIRAL INTERLEUKIN-6 (vIL-6) AND VIRAL CYCLIN D (vCD) GENES IN AIDS-RELATED KAPOSI'S SARCOMA CELLS BY ANTI-HIV PLANT PROTEIN MAP30
SEQUENCE POLYMORPHISM AND SEROPREVALENCE OF HHV-8 IN CENTRAL EUROPE
A SUBSET OF CD34+ HEMATOPOIETIC CELLS IN HIV-INFECTED INDIVIDUALS EXPRESS THE CD4, CXCR-4 AND CKR-5 RECEPTORS.
A new HHV-8+ EBV - B cell line (ISI-1) produces large amounts of IL10 and induces tumors in NOD/SCID mice
TISSUE AND BIOLOGICAL FLUIDS BANKS OF HIV-RELATED MALIGNANCIES
Oral 9-cis-Retinoic Acid is active in AIDS related Kaposi's sarcoma: AIDS Associated Malignancy Consortium Study 002
INTERIM ANALYSIS OF PHASE II STUDY (PROTOCOL L1057-28) OF PANRETIN™ CAPSULES (LGD1057, ALRT1057) FOR AIDS-RELATED KAPOSI'S SARCOMA
A MULTICENTER, PHASE II/III STUDY OF ATRAGEN™ (Tretinoin Liposomal) IN PATIENTS WITH AIDS-ASSOCIATED KAPOSI'S SARCOMA.
PRELIMINARY RESULTS OF IM-862 NASAL SOLUTION IN THE TREATMENT OF PATIENTS WITH AIDS-RELATED KAPOSI'S SARCOMA.
HUMAN HERPESVIRUS-8 (HHV-8) COMPARATIVE SERO-PREVALENCE IN U.S.A., INDIA, THAILAND, MALAYSIA, AND ITS ASSOCIATION WITH MALIGNANCIES.
HHV8 ANTIBODY SEROPOSITIVITY IS PREDICTIVE OF KS DEVELOPMENT IN HIV-1 INFECTED INDIVIDUALS.
HHV-8 Infection in Homosexual Men From New York City (NYC) and Washington (DC): Frequency, Risk Factors, and Relationship to Kaposi's Sarcoma (KS)
HHV-8-RELATED GAMMA HERPESVIRUSES AND DISEASE IN MACAQUES
THE TRANSCRIPTION PROGRAM OF THE KAPOSI'S SARCOMA-ASSOCIATED HERPESVIRUS HHV8
THE IMMUNOGENIC GLYCOPROTEIN GP35/37 OF HUMAN HERPESVIRUS 8 IS ENCODED BY OPEN READING FRAME K8.1
Human Herpesvirus 8 ORF 50 is Encoded in a Bi-Cistronic Message
Identification of Kaposin (ORF K12) as a Human Herpesvirus 8 (Kaposi's Sarcoma Associated Herpesvirus) Oncogene.
Identification of Four Major Subgroups and up to Ten Distinctive Clades of KSHV Genomes Based on Analysis of the Hypervariable ORF-K1 Membrane Receptor Protein
THE KSHV/HHV 8 G PROTEIN COUPLED RECEPTOR IS A VIRAL ONCOGENE AND ANGIOGENESIS ACTIVATOR
CHEMOKINE HUIP-10 INHIBITS CONSTITUTIVE SIGNALING OF KSHV G-PROTEIN-COUPLED RECEPTOR AND PROLIFERATION OF KSHV-INFECTED HUMAN B-CELLS.
INTERACTION BETWEEN INFLAMMATORY CYTOKINES AND HHV-8 INFECTED MONOCYTES ARE KEY TO THE DEVELOPMENT OF KAPOSI'S SARCOMA (KS)
CHARACTERIZATION OF KSHV/HHV-8 ACUTE INFECTION IN PRIMARY HUMAN BONE MARROW ENDOTHELIAL CELLS.
EXAMINATION OF KSHV INFECTION IN MULTIPLE MYELOMA PATIENTS
RELATIONSHIP BETWEEN RECREATIONAL DRUG USE AND DEVELOPMENT OF AIDS-LYMPHOMA (AIDS-NHL).
Latent Epstein-Barr virus infection as a risk factor for tumor development in AIDS patients
INFECTIOUS COMPLICATIONS IN PATIENTS WITH HIV- RELATED LYMPHOMA.
Primary cerebral Non-Hodgkin lymphoma (NHL) in AIDS - why is there an over-representation of homosexual male?
Association of significant cellular immune responses to synthetic peptides from the E6 and E7 oncoproteins of HPV-16 with disease-free condition in HPV+ patients treated for cervical intraepithelial neoplasia.
Long-term Remission of AIDS-related Primary Central Nervous System Lymphoma (PCNSL) with the Use of Highly Active Antiretroviral Therapy (HAART).
CONCOMITANT CHOP CHEMOTHERAPY (CT) AND HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART) IN PATIENTS (PTS) WITH HIV-RELATED NON-HODGKIN'S LYMPHOMA (HIV-NHL).
Malignancies associated with Pediatrie HIV infection: Long term survivors on highly active anti retroviral therapy (HAART)
SECOND-LINE CHEMOTHERAPY (CT) WITH CDE (CYCLOPHOSPHAMIDE, DOXORUBICIN, ETOPOSIDE) IN PATIENTS (PTS) WITH RESISTANT HUMAN IMMUNODEFICIENCY VIRUS-RELATED NON-HODGKIN'S LYMPHOMA (HIV-NHL)
PILOT TRIAL OF SAQUINAVIR AND NUCLEOSIDE ANALGOGUES PLUS INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN, AND ETOPOSIDE IN PATIENTS WITH HIV-ASSOCIATED NON-HODGKIN'S LYMPHOMA
The Protective Value of Chronic Acyclovir (or Ganciclovir/Foscarnet) Against AIDS-related Lymphoma: A Historical Cohort Study.
PRELIMINARY RESULTS OF PEG-L-ASPARAGINASE (ONCASPAR) IN THE TREATMENT OF RELAPSED/ REFRACTORY AIDS-RELATED LYMPHOMAS.
THE CANADIAN PHASE I-II TRIAL OF VACOP-B WITH FILGRASTIM FOR HIV RELATED NON HODGKIN'S LYMPHOMA (NHL): TOLERANCE AND DOSAGE STRATEGY.
A PHASE II STUDY OF DAILY SUBCUTANEOUS (SQ) LOW DOSE INTERLEUKIN-2 (IL-2), IN HIV-ASSOCIATED MALIGNANCIES.
Body cavity based lymphoma (BCBL) in an AIDS-patient during "successful" triple antiretroviral therapy - treatment and outcome.
PROSPECTIVE EVALUATION OF CLINICAL PROGNOSTIC FACTORS AND QUALITY OF LIFE (QOL) INDICES USING THE FUNCTIONAL LIVING INDEX-CANCER (FLIC) AND BRIEF SYMPTOM INVENTORY (BSI) IN PATIENTS WITH AIDS-RELATED NEOPLASMS.
BONE MARROW (BM) INVOLVEMENT IN AIDS-LYMPHOMA (AIDS-NHL): CLINICAL, IMMUNOLOGIC AND PATHOLOGIC FEATURES.
ELEVATED SERUM LEVELS OF SOLUBLE CD23 (sCD23) AND INTERLEUKIN 6 (IL 6) ARE ASSOCIATED WITH SMALL NON-CLEAVED/BURKITT'S LYMPHOMAS IN HIV-INFECTED PERSONS.
INTERLEUKIN 6 (IL6) SERUM LEVELS IN HIV-RELATED NON-HOGKINS'S LYMPHOMA (NHL): FROM "RESPONSE TO TREATMENT" TO "INSTRUCTIONS FOR USE"?
IMMUNOGLOBULIN SPECIFICITIES OF AIDs RELATED LYMPHOMA.
THE STATUS OF BCL-6, CD138/SYNDECAN-1, LMP-1 AND BCL-2 IDENTIFIES DISTINCT CATEGORIES OF AIDS-RELATED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: PATHOGENETIC AND HISTOGENETIC IMPLICATIONS.
EVIDENCE FOR HIV MEDIATED CIS-ACTIVATION OF THE c-fes PROTOONCOGENE IN A SUBSET OF AIDS ASSOCIATED LYMPHOMAS
HIV-ASSOCIATED NEOPLASTIC DEMENTIA: A MODEL IMPLICATING A ROLE FOR CLONAL MACROPHAGES.
CERVICAL CANCER CELL LINES AND CERVICAL BIOPSIES INDUCE LATENT HIV-1 IN THE U1 MONOCYTIC CELL LINE.
HEAD AND NECK CANCER IN HIV-INFECTED PATIENTS: ASSOCIATION OF HUMAN PAPILLOMAVIRUS (HPV) AND SQUAMOUS CELL CARCINOMA
MUTAGENICITY OF AZT IN THE HUMAN LYMPHOBLASTOID CELL LINE, TK6.
RELATIONSHIPS BETWEEN I-KAPPA B ALPHA CONSTITUTIVE EXPRESSION, TNF ALPHA SYNTHESIS, CELL CYCLE AND APOPTOSIS IN EBV-INFECTED LYMPHOBLASTOID CELL LINE.
A HIGH FREQUENCY OF MICROSATELLITE ALTERATIONS CHARACTERIZES HIV ASSOCIATED LUNG CARCINOMAS
Cutaneous T-cell lymphoma Mycoses Fungoldes (M.F.) in a pigtail macaque: Detection of an EBV-like virus.
CXCR4 AND CCR5 EXPRESSION DURING HUMAN B-CELL DEVELOPMENT.
Molecular analyses of VH and VL genes used by 7 cases of Primary Effusion Lymphomas (PEL) disclose the presence of somatic mutations indicative of antigen selection.
AIDS-ASSOCIATED LYMPHOMA MAY BE COMPOSED OF POLYCLONAL B-CELLS, OR CONSIST OF A MONOCLONAL PROCESS WITHIN A SKEWED B-CELL POLYCLONAL BACKGROUND.
Non-Hodgkin's lymphoma in HIV+ and HIV− men and women in the San Francisco Bay Area: Risk factors by histologic type.
DIFFERENTIAL EXPRESSION OF BCL-6, CD 138/SYNDECAN-1 AND EBV-ENCODED LATENT MEMBRANE PROTEIN-1 IDENTIFIES DISTINCT HISTOGENETIC SUBSETS OF AIDS-RELATED NON-HODGKIN'S LYMPHOMAS.
PHENOTYPIC PROFILE AND CHANGE IN CEREBROSPINAL FLUID EBV-DNA BURDEN DURING THERAPY AS PROGNOSTIC FACTORS IN AIDS-RELATED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA.
DISRUPTION OF EPSTEIN-BARR VIRUS (EBV) LATENCY IN EBV-POSITIVE TUMORS: A POTENTIAL METHOD FOR TREATING EBV-ASSOCIATED MALIGNANCY.
EFFECTS OF AZOTHYMIDINE AND INTERFERON ALPHA ON FAS/FAS-LIGAND IN AIDS RELATED LYMPHOMA.
Proliferation and apoptosis-related gene expression in experimental AIDS-related simian lymphoma.
Overview: Epidemiology of Malignancy in Immune-suppression
Epidemiologic Clues to the Etiology of Cancer in AIDS
EFFECT OF ANTIRETROVIRAL THERAPY ON RECENT TRENDS IN CANCERS AMONG HIV-INFECTED PERSONS
DECLINING INCIDENCE OF KAPOSI'S SARCOMA IN AIDS CLINICAL TRIAL GROUP (ACTG) TRIALS
Impact of Ilighly Effective Anti-retroviral Therapy on the Incidence of Malignancies Among HIV-infected Individuals
RISK FACTORS FOR AIDS ASSOCIATED NON-HODGKIN'S LYMPHOMA: A CASE-CONTROL STUDY.
Declines in AIDS Incidence Associated with Highly Active Anti-Retroviral Therapy (HAART) Are Not Reflected in KS and Lymphoma Incidence.
SURVEILLANCE AND CLINICAL MONITORING OF AIDS-RELATED MALIGNANCIES IN TWO U.S. MILITARY POPULATIONS, 1986-1996
EFFECT OF PROTEASE INHIBITOR THERAPY ON THE INCIDENCE OF HIV-ASSOCIATED MALIGANCIES AT AN URBAN MEDICAL CENTER.
State-of-the Art-and-Future Prospects: Clinical Issues - Kaposi's Sarcoma
AIDS-related lymphoma: where do we go from here?
Manifestations of HPV in transplant patients
HPV INFECTION AND ANOGENITAL NEOPLASIA IN MEN AND WOMEN: RECENT DEVELOPMENTS AND FUTURE CONSIDERATIONS
INTERNATIONAL ASPECTS OF HPV AND NEOPLASIA
Development of Small Molecule Inhibitors of the VEGF Receptor (Flk-1/KDR) for Treatment of Human Cancers.
KAPOSI'S SARCOMA-ASSOCIATED HERPESVIRUS (KSHV) VIL-6 AND LYMPHOPROLIFERATIVE DISORDERS.
Signal Transduction by Kaposi's Sarcoma-Associated Herpesvirus Transforming Protein K1
An overview of serology of IIIIV-8 (KSIIV).
HOST-VIRAL INTERACTIONS IN THE PATHOGENESIS OF KAPOSI'S SARCOMA
Mapping the origin of human B cell Non Hodgkin lymphomas and Hodgkin's disease onto normal B cell development. The role of the germinal center.
IMMUNODEFICIENCY-ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS.
EBV-RELATED MALIGNANCIES: THE ROLE OF LATENT MEMBRANE PROTEIN 1
EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOPROLIFERATIVE DISEASE AND VACCINES